Acuitas Therapeutics Inc. v. GlaxoSmithKline Biologicals SA et al
| Acuitas Therapeutics Inc. |
| GlaxoSmithKline LLC and GlaxoSmithKline Biologicals SA |
| 1:2025cv00003 |
| January 2, 2025 |
| U.S. District Court for the District of Delaware |
| Gregory B Williams |
| Patent |
| 28 U.S.C. § 2201 Declaratory Judgment |
| Plaintiff |
Docket Report
This docket was last retrieved on January 24, 2025. A more recent docket listing may be available from PACER.
| Document Text |
|---|
SO ORDERED, re #14 STIPULATION TO EXTEND TIME for Defendants to Answer the Complaint to through and including April 23, 2025 filed by GlaxoSmithKline Biologicals SA, GlaxoSmithKline LLC. Signed by Judge Gregory B. Williams on 1/24/2025. (lnb)
|
| Filing 15 WAIVER OF SERVICE returned executed by Acuitas Therapeutics Inc.: For GlaxoSmithKline Biologicals SA waiver sent on 1/23/2025, answer due 4/23/2025. (Sharp, Melanie) |
| Filing 14 STIPULATION TO EXTEND TIME for Defendants to Answer the Complaint to through and including April 23, 2025 - filed by GlaxoSmithKline Biologicals SA, GlaxoSmithKline LLC. (Farnan, Kelly) |
| Pro Hac Vice Attorney Nicholas Groombridge,Eric Alan Stone,Josephine Young,Allison C. Penfield,Ariella Barel,Nisha Gera,Chih-Wei Wu,Saurabh Gupta for Acuitas Therapeutics Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (scs) |
SO ORDERED, re #8 MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Josephine Young, Allison C. Penfield, Ariella Barel, Nisha Gera, Chih-wei Wu, and Saurabh Gupta filed by Acuitas Therapeutics Inc. Signed by Judge Gregory B. Williams on 1/9/2025. (lnb)
|
| Filing 13 SUMMONS Returned Executed by Acuitas Therapeutics Inc..GlaxoSmithKline LLC served on 1/2/2025, answer due 1/23/2025. (Sharp, Melanie) |
| Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) |
| Filing 12 REDACTED VERSION of #2 Complaint, by Acuitas Therapeutics Inc.. (Attachments: #1 Exhibit F, #2 Exhibit G, #3 Exhibit H)(Sharp, Melanie) |
| Filing 11 Pro Hac Vice Fee - Credit Card Payment received for Ariella Barel, Nisha Gera, Chih-Wei Wu, and Saurabh Gupta. ( re #8 MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Josephine Young, Allison C. Penfield, Ariella Barel, Nisha Gera, Chih-wei Wu, and Saurabh Gupta )( Payment of $ 200, receipt number ADEDC-4582019).(Sharp, Melanie) |
| Filing 10 Pro Hac Vice Fee - Credit Card Payment received for Nicholas Groombridge, Eric Alan Stone, Josephine Young, and Allison C. Penfield. ( re #8 MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Josephine Young, Allison C. Penfield, Ariella Barel, Nisha Gera, Chih-wei Wu, and Saurabh Gupta )( Payment of $ 200, receipt number ADEDC-4582014).(Sharp, Melanie) |
Filing 9
ORDER Granting #1 MOTION for Leave to File Complaint Under Seal. Signed by Judge Gregory B. Williams on 01/03/2024. (oam)
|
| Remark: Case Submitted for Routine Judicial Assignment (oam) |
| Filing 8 MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Josephine Young, Allison C. Penfield, Ariella Barel, Nisha Gera, Chih-wei Wu, and Saurabh Gupta - filed by Acuitas Therapeutics Inc. (oam) |
| Filing 7 Summons Issued as to GlaxoSmithKline Biologicals SA on 1/2/2025; GlaxoSmithKline LLC on 1/2/2025. (Attachments: #1 Summons Issued)(oam) ( |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Acuitas Therapeutics Inc.. (oam) |
| Filing 5 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,638,693; 11,638,694; 11,666,534; 11,766,401 ; 11,786,467. (oam) |
| Filing 4 EXHIBITS A-E to #2 Complaint, filed by Acuitas Therapeutics Inc. (Attachments: #1 Exhibit B, #2 Exhibit C, #3 Exhibit D, #4 Exhibit E)(oam) Modified on 1/2/2025 (nms). |
| Filing 3 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) |
| Filing 2 [SEALED] COMPLAINT for Declaratory Judgment of Non-Infringement and Invalidity with Jury Demand against GlaxoSmithKline Biologicals SA, GlaxoSmithKline LLC (Filing fee $ 405, receipt number ADEDC-4580889) - filed by Acuitas Therapeutics Inc.(Attachments: #1 Exhibit F, #2 Exhibit G, #3 Exhibit H)(oam) #4 Civil Cover Sheet) (oam). |
| Filing 1 MOTION for Leave to File Complaint Under Seal - filed by Acuitas Therapeutics Inc. (Attachments: #1 Proposed Order)(oam) Modified on 1/2/2025 (nms). |
| CORRECTING ENTRY: The pdfs for the summons issued at D.I. #7 have been amended. The assigned case number for the case has been added to the captions. The NEF for D.I. #7 has been regenerated. (nms) |
| Remark: Exit Electronic Copies to GBW. (oam) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
SO ORDERED, re #14 STIPULATION TO EXTEND TIME for Defendants to Answer the Complaint to through and including April 23, 2025 filed by GlaxoSmithKline Biologicals SA, GlaxoSmithKline LLC. Signed by Judge Gregory B. Williams on 1/24/2025. (lnb)